Dr Alfred J Ranieri Jr, MD | |
1455 Chapel St, New Haven, CT 06511-4403 | |
(203) 624-0103 | |
Not Available |
Full Name | Dr Alfred J Ranieri Jr |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 1455 Chapel St, New Haven, Connecticut |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932126448 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 015611 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Alfred J Ranieri Jr, MD 1455 Chapel St, New Haven, CT 06511-4403 Ph: (203) 624-0103 | Dr Alfred J Ranieri Jr, MD 1455 Chapel St, New Haven, CT 06511-4403 Ph: (203) 624-0103 |
News Archive
Aalto University neuroscientists, in collaboration with researchers at Helsinki University Hospital and Harvard Medical School, have found a novel connection between the size of the choroid plexus in the brain and complex regional pain syndrome (CRPS).
Millennium: The Takeda Oncology Company today announced the presentation of results from an ongoing Phase II study of MLN8237, an investigational Aurora A kinase inhibitor, in patients with relapsed/refractory aggressive B-cell and T-cell non-Hodgkin lymphoma.
The past few years have seen an explosion of heroin abuse and deaths from opiate overdose. But little is known about the molecular underpinnings of heroin addiction.
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
In a recent discovery by University of Minnesota Medical School, researchers uncovered a new way to potentially target and treat late-stage colorectal cancer - a disease that kills more than 50,000 people each year in the United States.
› Verified 9 days ago
Lynn E Fiellin, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 800 Howard Ave, Yale Physicians Building, New Haven, CT 06519 Phone: 203-688-2471 | |
Dr. Stephan Nicholas Lefcoski, MD General Practice Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Lihi Atzmony Maoz, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-785-4110 | |
Andrew Hong, MD General Practice Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Mallick Qaiser Alam, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 77 Grand Ave, New Haven, CT 06513 Phone: 203-562-8697 Fax: 203-562-1822 | |
Dr. Cynthia Zywocinski, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 92 Everit St, New Haven, CT 06511 Phone: 800-418-2554 | |
Walter N Kernan, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 789 Howard Ave, New Haven, CT 06519 Phone: 203-688-2471 Fax: 203-688-4516 |